A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 35/76 (2006.01) A61K 38/10 (2006.01) A61K 38/16 (2006.01) A61K 38/48 (2006.01) C07K 14/05 (2006.01) C07K 14/705 (2006.01) C07K 16/28 (2006.01) C12N 9/64 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2203364
Binding agents to CD11b, CD11c, CD21, CD23, a 70 to 85 KDa protein expressed on endothelial cells or a 115 KDa protein expressed on endothelial cells, can be useful in the treatment of inflammatory, autoimmune or allergic disease.
Agents de liaison à CD11b, CD11c, CD21, CD23, une protéine de 70 à 85 KDa exprimée dans les cellules endothéliales ou une protéine 115 KDa exprimée dans les cellules endothéliales, utiles dans le traitement des maladies inflammatoires, autoimmunes ou allergiques.
Bonnefoy Jean-Yves Marcel Paul
Lecoanet-Henchoz Sybille
Glaxo Group Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Binding agents for treatment of inflammatory, autoimmune or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Binding agents for treatment of inflammatory, autoimmune or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Binding agents for treatment of inflammatory, autoimmune or... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1677158